Home Twitter Page 5

Twitter

Latest

The Misleading Marketing of “Low-T” Drugs

Pharma Guy - January 1, 2014

Trish Nettleship: UCB Embraces Social Media with Strong Pharmacovigilance

Pharma Guy - January 1, 2014

PharmaGuy of Newtown Supports Science

Pharma Guy - January 1, 2014

Pharmaguy’s Insights on Pharma Industry News: 6 December 2016 Edition

Pharma Guy - January 1, 2014

Pain Patients Speak In Favor of Direct-to-Consumer Promotion by Pharma of...

Pharma Guy - January 1, 2014

Patient Centricity & Pharma’s Reputation

Pharma Guy - January 1, 2014

Patients Speak For and Against Direct-to-Consumer Off-Label Promotion of Drugs

Pharma Guy - January 1, 2014

Paul Ivans: Seeking Clarification on FDA Guidance Regarding Placement of Promotional...

Pharma Guy - January 1, 2014

Peter Houston: Could Pharma Use Tumblr and Survive?

Pharma Guy - January 1, 2014

Peter Kirk: Sermo vs. Doximity = “Facebook” vs. “LinkedIn” for Docs

Pharma Guy - January 1, 2014

1...456...11 Page 5 of 11

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026

The Trust Ceiling: Why Some Pharma Brands Can’t Improve Perception—No Matter...

April 16, 2026